Home > Boards > US OTC > Biotechs >

GenoMed Inc. (GMED)

Add GMED Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 6/26/2020 1:48:11 PM - Followers: 42 - Board type: Free - Posts Today: 0


Shares outstanding per the transfer agent 02/02/09: 221,170,711

04/27/09: Genomed Swine Flu Play?

Nature Medicine Articles Support GenoMed's Pending Patent on Bird Flu
GenoMed's Universal Approach to Viral Diseases Includes Avian Flu (Bird Flu) As Well as SARS and Influenza A


'Cytokine Storm' Paper Confirms GenoMed's Approach to Avian Flu


GenoMed and Italian NIH to Collaborate in Finding a Cure for Bird Flu in Poultry


Annals Publishes GenoMed, Inc. Approach To Avian Influenza


GenoMed Urges President Bush to Avoid Costly Avian Flu Mistake


GenoMed CEO Invited to Lecture at University of Chicago About Bird Flu


GenoMed’s WNV Treatment May Work for Avian Influenza



Genomed - Preventive Molecular Medicine

Before posting on this board, please read the GMED BOARD LAW at the bottom of this iBox.

GenoMed, Inc.
9666 Olive Blvd.
Suite 310
St. Louis, MO 63132
Ticker Symbol: GMED
: http://genomed.com and http://www.thelatestmedicaltreatment.com/

GenoMed is a Next Generation DMtm company that uses medical genomics to improve patient outcomes. GenoMed is working to translate knowledge of medical genomics--the study of which genes cause disease--into clinical practice. We combine biotechnology with Disease Management (DM). We develop new and better drugs, we use existing drugs for new disease indications, and we uncover disease before symptoms arise. By studying disease genes, we hope to make medicine more proactive and disease prevention more effective.

Our goal is nothing short of a medical revolution: we aim to change the way medicine is practiced. Just as Microsoft brought us the Age of Personal Computing, GenoMed intends to be a leader in the Era of Genome-based Preventive Molecular Medicine. Indeed, we believe that our patent-pending ACE inhibitor treatment, if widely applied, could save 50% of healthcare costs worldwide over the next decade.

per http://www.thelatestmedicaltreatment.com/,

"Our goal is nothing short of a medical revolution: we aim to change the way medicine is practiced. Instead of waiting for symptoms to develop, we intend to diagnose disease before any signs are visible. Just as Microsoft brought us the Age of Personal Computing, GenoMed intends to be the leader in the Era of Genome-based Preventive Molecular Medicine."

12/08:Is the Era of Personalized Medicine (Almost) Really Here?

"...President-Elect Obama is promising to throw his weight behind personalized medicine in the upcoming administration says AP"

"...while in the Senate, Obama sponsored a personalized medicine bill himself that promoted the R&D necessary to develop genetic tests for certain drugs and to develop a "biobank" of information for researchers and federal funding for this research as well, says AP."

source: http://blog.bioethics.net/2008/12/is-the-era-of-personalized-medicine-almost-really/

"Master" Disease Gene/Fountain of Youth?

GenoMed has discovered and applied for patent protection on a treatment that could have wide-ranging use for over 150 common diseases that currently carry a dismal prognosis. These include diabetes and its complications (which affects 20 million in the United States alone), high blood pressure and its complications (which affects 60 million in the U.S.); emphysema and other smoking-related diseases; and many other serious diseases, including infection with HIV and progression to AIDS, common solid cancers such as lung, colon, pancreas, liver, and kidney; cancers of the blood-stream such as chronic leukemias, multiple myeloma, and lymphomas; and immune-mediated diseases such as multiple sclerosis, degenerative joint disease (osteoarthritis) and rheumatoid arthritis.

GenoMed has found that over-activity of a single enzyme, angiotensin I-converting enzyme ("ACE"), may be behind these diseases. The logical treatment is effective inhibition of the ACE enzyme, using the correct dose of the correct ACE inhibitor. As a class, ACE inhibitors have been in widespread use since the 1970's, and have a very well-known safety profile. The company has so far had dramatically positive results in the following diseases:
1. Chronic kidney failure due to adult-onset diabetes
2. Chronic kidney failure due to high blood pressure
3. Poor circulation due to high blood pressure
4. End-stage emphysema
5. Psoriasis

GenoMed Completes First Version of Healthchip(r) for Cancer Prediction

ST. LOUIS, April 20, 2005 -- GenoMed, Inc. (Pink Sheets GMED) a Next Generation Disease Management company, said today that it has constructed a Healthchip® which may serve as an early warning system for the top six common cancers in whites: breast, colon, lung, ovarian, pancreatic, and prostate.

GenoMed's Healthchip® is made up of many single nucleotide polymorphisms (SNPs). In internal testing, the Healthchip® correctly identified the type of cancer in 85% of cases. None of the normals were misdiagnosed. More testing is required to confirm these results.

The well known breast cancer genes, BRCA1 and BRCA2, account for only 5% of breast cancers in white women. GenoMed's SNPs may pick up the remaining 95% of sporadic breast cancer cases in white women, i.e. in women without a strong family history of breast cancer.

Said Dr. David Moskowitz, GenoMed's chairman and chief executive officer, "It's important for any screening test to have as few false positives as possible. GenoMed's Healthchip® currently has none."

The test for mutations in the BRCA1 and BRCA2 genes costs about $1,200, has been available for about a decade, and has been reimbursed by a handful of insurance plans for the past few years. GenoMed's test is currently available for research purposes only, and is not yet reimbursable by any health plan. Please contact Dr. Moskowitz at dwmoskowitz@genomed.com to inquire about GenoMed's testing program.

SEC Filings - GenoMed files

GenoMed has the solution to the coming pandemic.

April 19, 2006 - GenoMed to Offer Free Mumps Trial http://tools.thestreet.com/rmy/quotes.html?pg=qcn&guid={3D6172DA-7BE1-495A-9696-E13B4F9E8A9A}&am....

February 1, 2006 - GenoMed's Formula for Better Healthcare at Half the Price = GenoMed + President Bush's HSAs

January 11, 2006- Turkish Brothers With Virus But No Symtoms Confirm GenoMed's Approach to Bird Flu

December 29, 2005 - Q & A page. Many of us find it incredible that your solution to the Avian flu problem has not been accepted in mainsteam circles. We are sure it will be in thefuture. Have you been able recently to make progress in this area?

November 14, 2005 - 'Cytokine Storm' Paper Confirms GenoMed's Approach to Avian Flu

September 16, 2005 - GenoMed's WNV Treatment May Work for Avian Influenza; GenoMed Tries to Help President Bush Avoid Avian Flu Mistake

scientists say bird flu provokes an excessive immune reaction (Reuters)

Investor Relations:
David Moskowitz MD, MA(Oxon.), FACP
Chief Medical Officer
Phone: (314) 983-9933
Fax: (314) 983-9939


June 26, 2006- GenoMed Can Explain Link Between West Nile, Diabetes/Hypertension

June 21, 2006- GenoMedGenoMed CEO Invited to Lecture at University of Chicago about Bird Flu

June 5, 2006- GenoMed, West Nile Virus, and Counting Crows

May 2, 2006- MO Rep. Mott Oxford Congratulates GenoMed on Reversing Kidney Failure

April 12, 2006- GenoMed Awarded Second Patent, for Avoiding Dialysis in Acute Kidney Failure

March 9, 2006- GenoMed Agrees to Distribute Healthcare to India for Under $150 Per Patient Per Year

March 1, 2006- GenoMed Awarded Second Patent, for Avoiding Dialysis in Acute Kidney Failure

February 23, 2006- GenoMed Trial Results: Multiple Sclerosis—From Two Relapses a Year to None in 16 Months

February 22, 2006- GenoMed Trial Results: Sickle Cell Disease—From Daily Pain to None

February 21, 2006- GenoMed Trial Results: HIV--Viral Load Goes to Zero

November 28, 2005 - GenoMed Considers Offering Low-Cost Health Insurance to America's Uninsured

November 14, 2005 - 'Cytokine Storm' Paper Confirms GenoMed's Approach to Avian Flu

October 28, 2005 - GenoMed Scores 14th Victory Treating Neuroinvasive West Nile Virus in Humans

September 16, 2005 - GenoMed's WNV Treatment May Work for Avian Influenza; GenoMed Tries to Help President Bush Avoid Avian Flu Mistake

July 26, 2005 - GenoMed Submits 50th Provisional Patent

July 25, 2005 - GenoMed's Observation of Major Racial Difference in Prostate Cancer Confirmed

July 13, 2005 - GenoMed Joins International Disease Management Alliance

June 29, 2005 - GenoMed CEO Testifies Before Missouri Medicaid Reform Commission

June 24, 2005 - GenoMed's WNV Treatment Abruptly Stopped, Patient Deteriorates

June 21, 2005 - GenoMed's Method to Prevent Most Kidney Dialysis Featured on IKIDNEY.COM

June 16, 2005 - GenoMed Treats Its First Presumptive West Nile Virus Patient of 2005

June 14, 2005 - GenoMed to be Awarded Second Patent, for Treating Acute Kidney Failure Without Dialysis

June 07, 2005 - GenoMed Announces 3rd Year of its West Nile Virus Trial; Now Part of BioShield II

May 26, 2005 - GenoMed to be Awarded First Patent: Hastening Lung Maturation in Newborns.

May 03, 2005 - BioShield II Specifically Mentions GenoMed's Antiviral Approach.

April 20, 2005 - GenoMed Completes First Version of Healthchip(r) for Cancer Prediction.

April 07, 2005 - GenoMed Offers Treatment to Combat Effects of Smoking.

April 05, 2005 - GenoMed Speaks Today at 1st Annual World Congress Leadership Summit on Disease Management and Chronic Care

Mar. 31, 2005 - GenoMed, Inc. Issues Clarification
GenoMed, Inc. (Pink Sheets: GMED) has been advised that one or more Internet websites are recommending the purchase of the Company's stock, and that unsolicited electronic mail has been circulated encouraging the purchase of the Company's stock. The Company is not responsible for, and is unaware of the source of, such Internet activity and makes no comment about the accuracy of such communications. The Company's management does not comment on research reports or rumors concerning the Company's activities or stock price.

Mar. 24, 2005 - GenoMed's Dr. David Moskowitz Featured on Wall Street Reporter

Mar. 10, 2005 - GenoMed, Inc. Says New Medicare Legislation May Accelerate Acceptance of Its Therapy.

Mar 03, 2005 - GenoMed Finds Thousands of Cancer-Associated Genotypes.


Feb 15, 2005 - GENOMED INC. FILES PATENT APPLICATION Company Identifies Two Additional Cancer-Related Genes.

Jan 20, 2005 - West Nile Virus Encephalitis Victim's Family Wants to Increase Public Awareness of GenoMed's Clinical Trial.

Jan 13, 2005 - GenoMed Finds Two Genes Linked to Common Cancers.

Dec 13, 2004 - UC Irvine Researcher Confirms GenoMed’s Patent-Pending Discovery: ACE is Major Aging Gene, ACE Inhibition is Partial “Fountain of Youth”

July 13, 2004 - GenoMed and Italian NIH to Collaborate in Finding a Cure for Bird Flu in Poultry

July 06, 2004 - GenoMed Applies for Listing on American Stock Exchange

Recent Publications

1. From Pharmacogenomics to Improved Patient Outcomes: Angiotensin I-Converting Enzyme as an Example

2. Is Angiotensin I-Converting Enzyme a "Master" Disease Gene?

3. Is "Somatic" Angiotensin I-Converting Enzyme a Mechanosensor?

4. Pathophysiologic Implications of Angiotensin I-Converting Enzyme as a Mechanosensor: Diabetes

5. Why AT1R blockade makes sense for SARS

6. The Central Role of Angiotensin I-Converting Enzyme in Vertebrate Pathophysiology


****GMED BOARD LAW: The main objective for this moderated board is to keep it free of posts which do not add value to the discussion of the stock, while keeping the board balanced, clean, on-topic with due diligence kept up to date. All posts here should stay focused on GMED, along with any other information which pertains to or affects GMED, i.e. competition, FDA guidance, current events, T/A analysis. Pro and con debate is encouraged as long as the opinions are kept on a mature level, with the omission of personal jabs.



If moderation of this nature offends you, then this board is not for you.



Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
GMED News: Quarterly Report (10-q) 05/04/2021 04:28:55 PM
GMED News: Globus Medical Reports First Quarter 2021 Results 05/04/2021 04:15:00 PM
GMED News: Globus Medical Q1 2021 Earnings Preview 05/03/2021 05:35:38 PM
GMED News: Statement of Changes in Beneficial Ownership (4) 04/27/2021 04:19:52 PM
GMED News: Additional Proxy Soliciting Materials (definitive) (defa14a) 04/22/2021 04:14:33 PM
#1326   Not a very active board here-last post Aug 2019? invest007 06/26/20 01:48:11 PM
#1325   gmed- GLOBUS MEDICAL is a breakout above $50 TFMG 08/18/19 08:29:47 PM
#1322   FDA approval! http://www.bing.com/news/apiclick.aspx?ref=BDIGeneric&aid=5021FF6 flybabyfly 08/18/17 07:41:54 AM
#1321   Aegis started GMED at Buy today. 10 valuation ValueInvestor15 11/30/16 02:28:08 PM
#1320   Timber..... T695 11/08/16 04:55:26 PM
#1319   GMED valuation models show big upside before earnings: bit.ly/2fk5NgM ValueInvestor15 11/08/16 10:11:48 AM
#1318   Chart in reversal mode it seems: Good Luck. mlkrborn 01/16/13 11:04:45 AM
#1317   Nice~ Picked up a starter today with 50EMA pj McMulligan 01/15/13 04:30:37 PM
#1316   Globus Medical sees Q4 revs of $100.5 mln mlkrborn 01/15/13 02:39:26 PM
#1315   He's back; Harry Wickey 12/10/12 09:05:26 PM
#1314   Interesting stock here, watching this $11 range from adeezl 12/10/12 03:24:24 PM
#1313   With the " INTRO " on Ihub still rhumphre1 08/28/12 11:43:57 AM
#1312   Yes, unfortunately. The new company's IPO opened at dxc226403 08/20/12 11:33:52 AM
#1311   Here is the link to the OLD company.........http://www.genomed.com/about-us.html rhumphre1 08/20/12 11:10:00 AM
#1310   They sure are worthless. The new company rhumphre1 08/20/12 10:35:49 AM
#1309   so igeuss our old shares are dead from gmed noode12 08/19/12 04:12:49 PM
#1308   I guarantee you if the " DR's name rhumphre1 08/06/12 01:39:50 PM
#1307   Obviously not the same company. midastouch017 08/03/12 11:42:48 AM
#1306   Reborn??? Globus Medical Announces Pricing of Initial Public Offering midastouch017 08/03/12 09:02:35 AM
#1305   Dr. David Moskowitz, GenoMed’s CEO rhumphre1 05/06/10 11:52:03 AM
#1304   Have you tried contacting Dr. Moscowitz? Is he EnergyGuy62 04/19/10 08:13:28 PM
#1303   The OZ is gone! rhumphre1 04/15/10 06:25:59 PM
#1302   Why does it take $50,000 to submit financials EnergyGuy62 03/28/10 11:02:01 PM
#1301   Why does it take $50,000 to submit financials EnergyGuy62 03/28/10 11:01:38 PM
#1300   The trouble is, is that it is still Harry Wickey 03/24/10 01:25:39 PM
#1299   i guess you didn't know if it is lottoplayerslair 03/23/10 09:04:54 PM
#1298   To get it off their account and be Harry Wickey 03/23/10 06:04:03 PM
#1297   why would some one dump 730k for nothing? lottoplayerslair 03/23/10 05:15:44 PM
#1296   so on grey sheets now crippled and hobbled. lottoplayerslair 03/18/10 06:23:05 PM
#1295   It traded yesterday and today. It was suspended Harry Wickey 03/18/10 05:09:04 PM
#1294   moneymade i guess you know gmed is not lottoplayerslair 03/18/10 04:46:29 PM
#1293   SEC Suspends Trading in GenoMed Shares; Company's Response midastouch017 03/04/10 11:23:54 PM
#1292   been following since 2000. Met Moskowitz in FL dshade 01/03/10 08:17:30 PM
#1291   Civil Rights Activist Lawrence Guyot Supports GenoMed midastouch017 12/27/09 12:10:10 PM
#1290   Successful promotional campaigns don’t happen by chance. sam1933 12/04/09 10:33:53 PM
#1289   GenoMed Partners with The Mane Event to Eradicate midastouch017 11/24/09 12:02:02 AM
#1288   GenoMed to MO Gov. Nixon: "We Can Save midastouch017 11/16/09 01:30:35 PM
#1287   Why was there any movement on this stock Makesalotofcents 10/12/09 10:05:04 PM
#1286   For a number of years I've been sending nextofkin 09/23/09 10:47:20 AM
#1285   What can GMED shareholders do to raise our midastouch017 09/22/09 02:55:03 PM
#1284   Prevention is the best move to counter the sam1933 08/27/09 06:44:47 AM
#1283   History repeating itself? ... We'll Find Out Soon. sam1933 08/27/09 05:11:28 AM
#1282   “If we’re doing a good job in the sam1933 08/25/09 09:26:21 PM
#1281   GenoMed's earlier memorandum: the story in full>>>>>>>>>>> sam1933 08/25/09 07:59:30 PM
#1280   GenoMed in Discussions with Philippines Dept of Health midastouch017 08/25/09 12:16:19 PM
#1279   In the Media sam1933 08/20/09 07:30:21 PM
#1278   A 'New Age' Tuskegee Medical Crime? sam1933 07/24/09 05:04:11 AM
#1277   GenoMed’s Observation of Major Racial Difference in Prostate sam1933 07/22/09 08:09:56 AM
#1276   eps. Jeanette Mott Oxford and Rev. James Morris midastouch017 07/20/09 10:02:49 AM
#1275   Local business results for independent retail pharmacies near Pennypicks 07/10/09 10:11:49 AM
Consent Preferences